Podcasts about Rudolf Virchow

In Teil 1 unserer Podcast-Dokumentation "Krebs besiegen" geht es um die Krebsdiagnostik, bildgebende Verfahren und die ersten Schritte nach einer Diagnose, etwa bei Brustkrebs. Außerdem werfen wir einen Blick zurück in die Geschichte der Krebsmedizin, auf die Zellforschung von Rudolf Virchow, die insbesondere unser heutiges Wissen über Blutkrebs, Leukämien, prägte.

Hast du dir schon einmal Gedanken darüber gemacht, wie sich die Medizin in den kommenden Jahren verändern könnte? Wir leben in einer Zeit des Wandels – gesellschaftlich, geopolitisch und auch medizinisch. In meinem neuesten Video nehme ich dich mit auf eine Reise durch die Vergangenheit und die Zukunft der Medizin und teile meine Gedanken zu den Herausforderungen und Chancen, die vor uns liegen. Ich spreche über die Grundlagen unserer heutigen Medizin, geprägt von großen Persönlichkeiten wie Rudolf Virchow und Robert Koch. ❓Doch ich frage mich: Ist das materialistisch-naturwissenschaftliche Weltbild, das sie etabliert haben, noch zeitgemäß? ❓Oder brauchen wir einen neuen, ganzheitlicheren Ansatz, um die Gesundheit der Menschen besser zu fördern? Auch geopolitische Veränderungen spielen eine Rolle: Länder wie Indien und China bringen alternative medizinische Traditionen ein, die künftig stärker berücksichtigt werden könnten. Diese Entwicklungen bieten die Chance, altes Wissen mit neuen Ansätzen zu verbinden und ein neues Bewusstsein in der Medizin zu schaffen. Schau dir das Video an, wenn du erfahren möchtest, warum ich optimistisch in die Zukunft der Medizin blicke und was ich mir für eine positive Transformation im Gesundheitswesen wünsche. Lass dich inspirieren und diskutiere mit!

In this episode, CardioNerds Dr. Gurleen Kaur and Dr. Akiva Rosenzveig are joined by Cardio-Rheumatology experts, Dr. Brittany Weber and Dr. Michael Garshick to discuss treating inflammation, delving into the pathophysiology behind the inflammatory hypothesis of atherosclerotic cardiovascular disease and the evolving data on anti-inflammatory therapies for reducing ASCVD risk, with insights on real-world implementation. Show notes were drafted by. Dr. Akiva Rosenzveig. This episode was produced in collaboration with the American Society of Preventive Cardiology (ASPC) with independent medical education grant support from Lexicon Pharmaceuticals. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls - Treating Inflammation Our understanding of the pathophysiology of atherosclerosis has undergone a few iterations from the incrustation hypothesis to the lipid hypothesis to the response-to-injury hypothesis and culminating with our current understanding of the inflammation hypothesis. Both the adaptive and innate immune systems play instrumental roles in the pathogenesis of atherosclerosis. After adequately controlling classic modifiable risk factors such as blood pressure, dyslipidemia, glucose intolerance, and obesity, systemic inflammation as assessed by CRP can be ascertained as CRP is associated with ~1.8-fold increased risk of cardiovascular events Although the most common side effect of colchicine is gastrointestinal intolerance, colchicine can induce lactose intolerance, so a lactose free diet may help ameliorate colchicine-induced GI symptoms. Anti-inflammatory therapeutics have shown promise in reducing cardiovascular risk but much more is to be learned with ongoing and future basic, translational, and clinical research. Show notes - Treating Inflammation What are the origins of the inflammatory hypothesis? The first hypothesis as to the pathogenesis of atherosclerosis was the incrustation hypothesis by Carl Von Rokitansky in 1852. He suggested that atherosclerosis begins in the intima with thrombus deposition.In 1856, Rudolf Virchow suggested the lipid hypothesis whereby high levels of cholesterol in the blood lead to atherosclerosis. He observed inflammatory changes in the arterial walls associated with atherosclerotic plaque growth, called endo-arteritis chronica deformans.In 1977, Russell Ross suggested the response-to-injury hypothesis, that atherosclerosis develops from injury to the arterial wall.In the 1990's the role of inflammation in ASCVD became more recognized. Both the adaptive and innate immune system are critical in atherosclerosis. Lipids and inflammation are synergistic in that lipid exposure is required but they translocate through damaged endothelium which occurs by way of inflammatory cytokines, namely within the NLRP3 inflammasome (IL-1, IL-6 etc.).Smooth muscle cells are also involved. They migrate to the endothelial region and secrete collagen to create the fibrous cap. They can also transform into macrophage-like cells to take up lipids and become foam cells. T, B, and K cells are also part of this milieu. In fact, neutrophils, macrophages and monocytes make up only a small portion of the cells involved in the atherosclerotic process. What are ways to individually optimize one's ASCVD risk?Ensure the patient is on appropriate antiplatelet therapy, lipid lowering therapy, blood pressure is well controlled, and the Hemoglobin A1c is well controlled. Smoking cessation is pivotal.If the patient has an elevated Lipoprotein (a), pursue more aggressive lipid lowering therapy. Targeted therapies may become available in the future. Assess the patient's systemic inflammatory risk as measured by C-Reactive Protein (CRP)

Der 1821 geborene Rudolf Virchow war ein Universalgelehrter und ein politisch aktiver Sozialreformer. Bis heute ist er präsent als ein Begründer der modernen Medizin.

Regresamos hoy con un nuevo Flashback del programa recuperado de nuestro especial 20 aniversario de 2016. Hoy toca hablar de ciencia y de divulgación científica y lo hacemos, además de con un breve recuerdo a Carl Sagan, con un personaje muy interesante que nos presenta el Dr. Alberto Cabañas: Rudolf Virchow: un médico y biólogo alemán del Siglo XIX que nos ayudó a entender mucho mejor el cuerpo humano. Pero hoy no hablaremos tanto de su aportación puramente científica, sino más bien de su compromiso social y político como arma para la salud. Vamos a descubrirlo. Si te gusta el Abrazo del Oso y quieres acceder a más contenidos extra, puedes ayudarnos pinchando en el botón 'apoyar' aquí en iVoox. O pásate por www.patreon.com/elabrazodeloso ¡GRACIAS! www.elabrazodeloso.es Fragmento del programa emitido en octubre de 2016. www.latostadora.com/elabrazodeloso Canal de Telegram para estar informado: https://t.me/+T6RxUKg_xhk0NzE0 Grupo abierto de Telegram para conversar con el equipo y la audiencia: https://t.me/+tBHrUSWNbZswNThk Twitch: https://www.twitch.tv/elabrazodeloso Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

Does high cholesterol really cause heart disease? Is there such as thing as “good” and “bad” cholesterol? What impact do statins – the most profitable drug in the history of medicine – have on human health? In this episode, Dr Malcolm Kendrick, author of The Great Cholesterol Con and The Clot Thickens, joins us to challenge the conventional wisdom on cholesterol. He shares his view on the diet-heart hypothesis, his intriguing alternative explanation for heart disease, and what he recommends to maintain a healthy heart. We also discuss how and why fiat medicine and economics have many “endlessly adaptable hypotheses" that refuse to die no matter how much reality assaults them.ReferencesDr Kendrick on Twitter.Dr Kendrick's website.Dr Kendrick's books: The Great Cholesterol Con, Doctoring Data and The Clot ThickensEuropean cardiovascular disease statistics 2008 edition showing lower cardiovascular disease prevalence in countries with higher saturated fat in the diet. For more on this topic, see this blog post by Dr Kendrick.Website of the International Network of Cholesterol ScepticsDr Kendrick's blog post on Carl von Rokitansky and Rudolf Virchow and the 1852 explanation of heart disease. Saifedean's first book, The Bitcoin Standard.Saifedean's second book, The Fiat Standard.Enjoyed this episode? You can take part in podcast seminars, access Saifedean's courses – including his ongoing course ECO22: The Fiat Standard – and read chapters of his forthcoming books by becoming a Saifedean.com member. Find out more here.

Berlin blickt auf eine lange Tradition der medizinischen Forschung zurück, beginnend mit der „Berliner Schule der Medizin“, die unter anderem von Hermann von Helmholtz und Rudolf Virchow mitbegründet wurde. Aus ihr wurde die Gesundheitsregion Berlin- Brandenburg mit einer vielfältigen Forschungslandschaft, den Universitäten, der Charité und einer modernen Gesundheitswirtschaft. Ursula Nonnemacher (Ministerin für Soziales, Gesundheit, Integration und Verbraucherschutz des Landes Brandenburg), Angelika Eggert (Charité – Universitätsmedizin Berlin, Akademiemitglied) und Daniel-Jan Girl (Präsident der Industrie- und Handelskammer Berlin) diskutieren über die Zukunft Berlins als einer Stadt, die auf eine humanitäre Wissenschaft und Gesundheit setzt. Moderiert von Britta Rutert (Wissenschaftliche Koordinatorin IAG „Zukunft der Medizin – Gesundheit für alle“). Den Originalbeitrag und mehr finden Sie bitte hier: https://lisa.gerda-henkel-stiftung.de/salonsophiecharlotte22_gesundheitsregion

Berlin blickt auf eine lange Tradition der medizinischen Forschung zurück, beginnend mit der „Berliner Schule der Medizin“, die unter anderem von Hermann von Helmholtz und Rudolf Virchow mitbegründet wurde. Aus ihr wurde die Gesundheitsregion Berlin- Brandenburg mit einer vielfältigen Forschungslandschaft, den Universitäten, der Charité und einer modernen Gesundheitswirtschaft. Ursula Nonnemacher (Ministerin für Soziales, Gesundheit, Integration und Verbraucherschutz des Landes Brandenburg), Angelika Eggert (Charité – Universitätsmedizin Berlin, Akademiemitglied) und Daniel-Jan Girl (Präsident der Industrie- und Handelskammer Berlin) diskutieren über die Zukunft Berlins als einer Stadt, die auf eine humanitäre Wissenschaft und Gesundheit setzt. Moderiert von Britta Rutert (Wissenschaftliche Koordinatorin IAG „Zukunft der Medizin – Gesundheit für alle“). Den Originalbeitrag und mehr finden Sie bitte hier: https://lisa.gerda-henkel-stiftung.de/salonsophiecharlotte22_gesundheitsregion

"A culture war is a cultural conflict between social groups and the struggle for dominance of their values, beliefs, and practices.[1] It commonly refers to topics on which there is general societal disagreement and polarization in societal values. Its contemporary use refers to a social phenomenon in which multiple social groups, holding distinct values and ideologies, attempt to steer public policy in opposition to each other,[2][3] thus a culture war now describes "hot button" or "polarizing" social issues in politics and public policy.[4] These include wedge issues such as abortion, homosexuality, transgender rights, pornography, multiculturalism, racism, and other cultural conflicts based on values, morality, and lifestyle which are described as the major political cleavage.[4] The term culture war is a loan translation (calque) of the German Kulturkampf ('culture struggle'). In German, Kulturkampf, a term coined by Rudolf Virchow, refers to the clash between cultural and religious groups in the campaign from 1871 to 1878 under Chancellor Otto von Bismarck of the German Empire against the influence of the Roman Catholic Church.[5] The translation was printed in some American newspapers at the time.[6]" --- Send in a voice message: https://anchor.fm/antonio-myers4/message Support this podcast: https://anchor.fm/antonio-myers4/support

Today, as we return to the topic of professional development to discuss the good, the bad and the ugly of pandemic PD and what PD may look like in the future. We kick off our episode with a goofy question: If you could attend a PD workshop run by any person (scientist, author, teacher, etc) whose workshop would you want to attend? - Joining us from Missouri is Kelly Kluthe: Maybe because yesterday was Darwin Day, but I'm going with the obvious Charles Darwin pick. - Joining us from Texas is Lee Ferguson: I'll go with Rudolf Virchow, because I have to know, is that story about you giving that politician dude a worm-infested sausage and daring him to eat it true? Also, I think it would be cool to learn from Sean Carroll. - Joining us from Colorado is Hannah Hathaway: Just because I want to meet and chat with this person, I'll go with Ira Flatow. - Aaron: Terry Gross from Fresh Air or Rosalind Franklin, Questions We Discuss: - What have you missed most about face-to-face PD over the past 2 years? - Have you had any really good PD through remote platforms over the past 2 years? - Do you have any PD plans in the coming months? Do you think you will have face-to-face PD anytime soon? Credits: Please subscribe to Life of the school on your podcast player of choice! Patreon: https://www.patreon.com/LOTS Music by: https://exmagicians.bandcamp.com/ Show Notes at Lifeoftheschool.org You can follow on twitter @MrMathieuTweets or @lifeoftheschool

Rudolf Virchow legte stets besonderes Augenmerk auf den Zusammenhang von unreinem Trinkwasser und Ausbrüchen von Epidemien. Als im Jahr 1866 über 8.000 Berliner an Cholera erkrankten, von denen mehr als 6.000 starben, wurden erstmals genaueste statistische Erhebungen, insbesondere zu den örtlichen Verhältnissen, durchgeführt. Virchow widmete sich diesen ebenso wie dem Bau der Kanalisation und der Anlage der Rieselfelder intensiv. Den großen Anteil Rudolf Virchows an der Einführung der Kanalisation, mit der die hygienischen Verhältnisse in Berlin verbessert und so die Sterbe- und Krankheitsrate deutlich gesenkt werden konnte, zeigt die Leiterin des Akademiearchivs Vera Enke. Den Originalbeitrag und mehr finden Sie bitte hier: https://lisa.gerda-henkel-stiftung.de/sophie_charlotte_2121

Rudolf Virchow legte stets besonderes Augenmerk auf den Zusammenhang von unreinem Trinkwasser und Ausbrüchen von Epidemien. Als im Jahr 1866 über 8.000 Berliner an Cholera erkrankten, von denen mehr als 6.000 starben, wurden erstmals genaueste statistische Erhebungen, insbesondere zu den örtlichen Verhältnissen, durchgeführt. Virchow widmete sich diesen ebenso wie dem Bau der Kanalisation und der Anlage der Rieselfelder intensiv. Den großen Anteil Rudolf Virchows an der Einführung der Kanalisation, mit der die hygienischen Verhältnisse in Berlin verbessert und so die Sterbe- und Krankheitsrate deutlich gesenkt werden konnte, zeigt die Leiterin des Akademiearchivs Vera Enke. Den Originalbeitrag und mehr finden Sie bitte hier: https://lisa.gerda-henkel-stiftung.de/sophie_charlotte_2121

Hermann von Helmholtz und Rudolf Virchow feiern in diesem Jahr ihre 200. Geburtstage. Im 19. Jahrhundert haben sie Grundlegendes zum Wandel des Lebensbegriffes beigetragen. Hier sehen Sie die Faksimiles der Titelseiten zweier Reden, die die großen Forscher im Jahr 1877 gehalten haben. Historiker und Akademiemitglied Mitchell Ash stellt Ihnen anhand dieser Reden die Zugänge der beiden Forscher zum Lebensbegriff und zur Wissenschaftsfreiheit vor. Ein Beitrag der interdisziplinären Arbeitsgruppe „Wandel der Universitäten und ihres gesellschaftlichen Umfelds – Folgen für die Wissenschaftsfreiheit?“. Den Originalbeitrag und mehr finden Sie bitte hier: https://lisa.gerda-henkel-stiftung.de/sophie_charlotte_2113

Hermann von Helmholtz und Rudolf Virchow feiern in diesem Jahr ihre 200. Geburtstage. Im 19. Jahrhundert haben sie Grundlegendes zum Wandel des Lebensbegriffes beigetragen. Hier sehen Sie die Faksimiles der Titelseiten zweier Reden, die die großen Forscher im Jahr 1877 gehalten haben. Historiker und Akademiemitglied Mitchell Ash stellt Ihnen anhand dieser Reden die Zugänge der beiden Forscher zum Lebensbegriff und zur Wissenschaftsfreiheit vor. Ein Beitrag der interdisziplinären Arbeitsgruppe „Wandel der Universitäten und ihres gesellschaftlichen Umfelds – Folgen für die Wissenschaftsfreiheit?“. Den Originalbeitrag und mehr finden Sie bitte hier: https://lisa.gerda-henkel-stiftung.de/sophie_charlotte_2113

Autor: Satori, Christina Sendung: Forschung aktuell Hören bis: 19.01.2038 04:14

Rudolf Virchow war Forscher, Sozialmediziner, Politiker und hat mit seinem Zellmodell die Medizin umgekrempelt. Vor genau 200 Jahren (13.10.1821) wurde der "rastlose Rudi" geboren. Welche Spuren er in Berlin hinterlassen hat, erklärt Prof. Thomas Schnalke, Direktor des Medizinhistorischen Museums der Berliner Charité.

Rudolf Virchow entwickelte die Zellularpathologie, nach der Krankheiten auf einer Störung der Körperzellen und ihrer Funktionen beruhen. Auch als Stadtverordneter machte er sich verdient. Seine Devise: "Politik ist nichts weiter als Medizin im Großen".

Heute vor 200 Jahren wurde der Arzt, Pathologe und Hygienepionier Rudolf Virchow geboren.

Rudolf Virchow zählt zu den Schlüsselgestalten des 19. Jahrhunderts. Er wirkte nicht nur als Arzt und Wissenschaftler, sondern auch als Sozialreformer. Autorin: Heide Soltau

Rudolf Virchow steht für das Ende eines über 2.000 Jahre alten Krankheitsbilds: Nicht die Mischung der Körpersäfte ist schuld, wenn der Mensch krank wird, sondern Störungen seiner Körperzellen. Auch die moderne Wasserversorgung und die Kanalisation Berlins gehen auf den engagierten Naturwissenschaftler zurück. (BR 2016)

Dr. Rupa Marya is an Associate Professor of Medicine at UC-San Francisco, an activist, author and musician. She was recently awarded the Chancellor's Award for Public Service. Dr. Marya also co-founded the Do No Harm Coalition, an organization of healthcare workers committed to overturning structural obstacles to health. She is also the co-author with Raj Patel of "Inflamed: Deep Medicine and the Anatomy of Injustice". Tune in to learn more about: - How social structures create diseases; - The teachings and writings of Rudolf Virchow and his recommendations about ways to improve people's health by improving their economic and social conditions; - The heartbreaking story of Shelia McCarley and how she was killed by her body's own response to her environment, poisoned by ongoing exposure to chemicals; - About the Do No Harm Coalition and their work; - The microbiome, the pandemic and why we are a composite of organisms; - Epigenetics and why what we eat today will have a great impact on the health of the next generations. To learn more about Dr. Rupa Marya go to: https://rupamarya.org/. 

Dr. Rudolf Virchow, one of the founders of scientific medicine, said that "Medicine is a social science, and politics is nothing more than medicine on a large scale." Beyond caring for the sick, doctors have played an important role in calling attention to the social determinants of health. International physicians for the prevention of nuclear war (IPPNW) played a pivotal role in the cessation of atmospheric nuclear weapons testing at the height of the cold war. This anti-weapons activism later came to be directed towards civilian nuclear energy by the likes of anti-nuclear crusader Dr. Helen Caldicott who is well known for her unwillingness to back up her outlandish claims with scientific evidence. Doctors for Nuclear Energy is a new international group of physicians who argue that nuclear energy is a keystone technology for the elimination of air pollution and CO2 emissions. Co-founders Dr. Van Der Merwe and Dr. Keefer share their perspectives on relative risk assessment, radiophobia and its public health consequences and our clean energy future. https://www.patreon.com/decouple?fan_landing=true https://www.doctorsfornuclearenergy.org/

Rudolf Virchow hatte sich als Arzt und Anthropologe einen Namen gemacht. Nach der Entdeckung des ersten Neandertaler-Skeletts lag er aber voll daneben. Seiner Ansicht nach gehörten die gefundenen Knochen einem Zeitgenossen, sein Beitrag unserer Reihe „Irrtümer der Wissenschaft“

In this episode we catch up with Dr Jonathon Tomlinson, an amazing GP in Hackney. Jonathan fills us in with how he is getting on during the coronavirus crisis. He shares his experience working in a practice in one of the hardest hit areas for coronavirus in the UK (1min 40). He tells me how his team has acted quickly to manage the acute situation but also continues to support the long term conditions for many of his patients in the community. We talk about some of the many changes in primary care over the last few weeks (5min 40s). These include; phone and video consultations; losing the GP waiting room; sharing clinical decisions and talking more with colleagues. We discuss the effects of coronavirus on those people living in deprivation (10mins 10s) and Jonathon shares some experiences from his practice and his patients (11mins). Jonathan talks about the social determinants of health and the importance of prevention along with all the stuff we are seeing in the media at the moment like PPE (14mins 50s) . One of the things that GPs can do is advocacy and Jonathon was keen to discuss the work of Dr Rudolf Virchow 1821-1902 (19mins). Virchow is famous for saying that politics is nothing but medicine on a large scale and that our role as doctors is to show the link between social conditions and medical diseases (21mins). Jonathan explains why Virchow's message is particularly relevant at the moment. We explore the role of a GP in advocacy and coordination of a response to support those who are most in need and vulnerable. We discuss how much our job in primary care should include advocacy on behalf of our patients (26mins) and Jonathon offers some ideas for some steps clinicians can take forward to achieve this. Jonathon mentions collaboration, networks (e.g. The Deep End Network), treating long term conditions. We finish our conversation talking about the importance of caring for our patients (28m 55s), Jonathon shares his favourite book (32m 10s), and he tells us what his magic genie wish would be (34m 40s). Jonathon's recommended BookLet Us Now Praise Famous Men by James Agee (photographs by photographer Walker Evans)Other reading“Caring Effects” Julian Tudor-Hart and Paul Dieppe (mentioned at 30mins 50s)Jonathon's excellent blogMy (Rachel's) favouritesIf you want to learn more about advocacy and Rudolf Virchow Jonathon has written lots about trauma informed care but this one will get you startedCoronavirus consulting and more about Jonathon's experiences over the last few monthsYou can also find Jonathon on tweeting on being a GP and topics related our discussion @mellojonny See acast.com/privacy for privacy and opt-out information.

Vers la compréhension de l'apparition du cancer et des premières pistes sérieuses de traitement. Dans l'épisode précédent, nous avions évoqué les nouvelles idées de la Renaissance, et l'influence de scientifiques telles que Vésale, Pecquet ou Pott. Dans ce nouvel épisode, nous évoquerons le XIXème siècle : un siècle pivot car c'est à cette époque que les scientifiques font des découvertes précises sur la genèse du cancer et que des pistes de plus en plus crédibles pour le guérir sont testées. Nous prendrons donc le temps d'évoquer des scientifiques tels que Rudolf Virchow, Henri Becquerel, ou encore Marie et Pierre Curie.

Bienvenidos a un nuevo episodio de DoctorTopic Radio, el podcast dirigido a médicos, en el que compartimos contenido útil para la práctica clínica diaria y reflexionamos sobre todo lo que rodea al mundo de la medicina. Hoy tratamos la cirugía bariátrica. Hablamos de cómo de segura es la cirugía contemporánea, repasamos las técnicas quirúrgicas más frecuentemente utilizadas y cuáles son los mecanismos que hay detrás de la pérdida de peso. Pero antes de empezar con el monográfico, estrenamos una nueva sección de historia comentando los hitos más destacados de la vida del Dr. Rudolf Virchow.  Es una sección que todavía no tiene nombre, ayúdanos a ponerle nombre dejando tu idea en alguna de nuestras redes sociales.  Esperamos que os haya resultado útil, muchas gracias por acompañarnos en esta aventura y ¡nos escuchamos la semana que viene! Ya sabéis que apreciamos vuestro feedback, así que para cualquier comentario, duda o sugerencia, o si queréis proponer un tema para el podcast, podéis contactar con nosotros en doctortopic.com/contacto. ¡Gracias por vuestros comentarios positivos, likes y valoraciones de 5 estrellas ya sea en Itunes, Ivoox o spotify, y por compartir el podcast con vuestros compañeros! Créditos: Música entrada“Hotshot”. Inspiring & Upbeat Music by Scott Holmes licensed under a Attribution-NonCommercial License

Do you know what Operation Chrome Dome is? Do you know that it nearly caused North Carolina to be obliterated off the map? Bet you didn't learn about that in your history class. Did you also know that in 1847, Dr. Ignaz Semmelweis (the first doctor to say, "Hey, maybe we should wash our hands before treating patients") died in an insane asylum because nobody, including famous doctor Rudolf Virchow, believed him? Learn more in the newest episode of Better Than Human where Jennifer and Amber, the sassy sisters, dig in to some of the stupidest things humans have ever done. Follow us on Twitter @betterthanhuma1on Facebook @betterthanhumanpodcaston Instagram @betterthanhumanpodcastOr email us at betterthanhumanpodcast@gmail.comWe look forward to hearing from you, and we look forward to you joining our cult of weirdness.

This week, surgery will get a helping hand from some great scientists, who pave the way for the field of pathology, or the study of the causes of disease. We'll talk about James Paget, Rudolf Virchow, and Robert Koch, each of whom contributed significantly to our understanding and the diagnosis of diseases. Website: http://thehistoryofmedicine.buzzsprout.com/E-mail: thehistoryofmedicinepodcast@gmail.comFacebook: https://www.facebook.com/TheHistoryOfMedicine/Transcripts and Sources here!

Scottish doctor, writer, speaker, and outspoken cholesterol sceptic Malcolm Kendrick is back on the podcast this week. He continues to challenge the widespread use of statin medications, despite being targeted personally and professionally by those opposing his message. Since we last talked he has authored a new book, A Statin Nation: Damaging Millions in a Brave New Post-health World, elucidating his position against mainstream medicine’s rampant cholesterol-lowering tactics.  On this podcast, Dr. Kendrick describes in detail exactly what he believes drives the process of cardiovascular disease, informed from 35 years of research on the subject.  He explains specifically why cholesterol has been misunderstood, and how medicine got it wrong. We discuss corruption in medical research and the money supporting the status quo, and Dr. Kendrick shares some of the best ways to avoid heart disease (which have little to do with diet!). Here’s the outline of this interview with Malcolm Kendrick: [00:00:07] Our first podcast with Malcolm Kendrick: Why Cholesterol Levels Have No Effect on Cardiovascular Disease (And Things to Think about Instead). [00:00:30] Book: A Statin Nation: Damaging Millions in a Brave New Post-health World, by Dr. Malcolm Kendrick. His previous two books: Doctoring Data and The Cholesterol Con. [00:02:00] Causes vs processes. [00:03:40] History behind his journey and questioning authority. [00:07:30] Articles written by Elspeth Smith. [00:09:00] Karl Rokitansky’s paper discussing an alternative way of looking at CVD: A manual of pathological anatomy, Vol. 4. Day GE, trans. London: Sydenham Society, 1852:261; in print here. [00:09:06] Rudolf Virchow, researcher who pointed to cholesterol in artery walls. [00:10:55] Researcher Nikolai N. Anichkov: fed rabbits a high-cholesterol diet and cholesterol appeared in their arteries (sort of). [00:12:07] Ancel Keys; blaming saturated fat. [00:14:11] France - highest saturated fat consumption, lowest rate of CVD. Georgia - lowest sat fat consumption, highest rate of CVD.  See graph, here. [00:15:16] International Network of Cholesterol Skeptics (THINCS). Study: Ravnskov, Uffe, et al. "Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review." BMJ open 6.6 (2016): e010401. [00:16:50] Pleiotropic effects of statins. [00:17:29] Movie: 12 Angry Men (1957). [00:20:30] Robert Ross - response to injury hypothesis; Study: Ross, Russell, John Glomset, and Laurence Harker. "Response to injury and atherogenesis." The American journal of pathology 86.3 (1977): 675. [00:20:40] TV show: Stranger Things. [00:22:31] Infectious disease hypothesis. [00:22:52] Analogy of rust in the paint of a car; Sickle Cell Disease as an example. [00:27:12] 14-year old boy with Sickle Cell and atherosclerosis; Study: Elsharawy, M. A., and K. M. Moghazy. "Peripheral arterial lesions in patient with sickle cell disease." EJVES Extra 14.2 (2007): 15-18. [00:28:57] Endothelial progenitor cells, produced in the bone marrow, discovered in 1997. [00:29:31] Pig study of endothelial turnover: Caplan, Bernard A., and Colin J. Schwartz. "Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta." Atherosclerosis 17.3 (1973): 401-417. [00:31:48] Vitamin C's role in maintaining collagen and blood vessels. [00:33:08] Lp(a) molecules - patching cracks in the artery walls. [00:33:42] Depriving guinea pigs of vitamin C caused atherosclerosis; Study: Willis, G. C. "The reversibility of atherosclerosis." Canadian Medical Association Journal 77.2 (1957): 106. [00:34:24] Linus Pauling - said CVD was caused by chronic low-level vitamin C deficiency. [00:35:53] What else damages endothelial cells? Many things, including smoking, air pollution, high blood sugar, Kawasaki disease, sepsis/infection. [00:41:19] Glycocalyx; Nitric oxide. [00:43:30] Health benefits of sun exposure. [00:44:26] Biomechanical stress (blood pressure) - atherosclerosis in arteries but not in veins. [00:47:57] Things that interfere with repair: steroids, vascular endothelial growth factor (VEGF) inhibitors. [00:55:00] The effects of stress on the cardiovascular system. [00:57:55] Red blood cells are what brings cholesterol into blood clots. [00:58:59] Cholesterol crystals in atherosclerotic plaques come from red blood cells. Study: Kolodgie, Frank D., et al. "Intraplaque hemorrhage and progression of coronary atheroma." New England Journal of Medicine 349.24 (2003): 2316-2325. [01:00:55] Very low-density lipoproteins (VLDLs) are procoagulant; High-density lipoprotein (HDL) is anticoagulant. [01:03:46] Familial hypercholesterolemia (FH); Factor VIII. [01:08:15] Cholesterol-lowering pharmaceuticals; Repatha. In the clinical trial, the total number of cardiovascular deaths was greater in the Repatha group than the placebo group. Study: Sabatine, Marc S., et al. "Evolocumab and clinical outcomes in patients with cardiovascular disease." New England Journal of Medicine 376.18 (2017): 1713-1722. [01:09:34] David Deamer, biologist and Research Professor of Biomolecular Engineering. [01:10:05] Karl Popper, philosopher. [01:10:28] Bradford Hill’s Criteria for Causation. [01:13:52] Michael Mosley, BBC journalist. [01:16:40] Statin denialism - an internet cult with deadly consequences? [01:19:18] The money behind the statin and low-fat industries. [01:20:06] Margarine; Trans-fatty acids, banned in several countries. [01:24:37] The impact of food; The focus on food to the exclusion of other pillars of health. [01:26:38] Dr. Phil Hammond; CLANGERS [01:28:21] Avoiding internet attacks. [01:32:00] ApoA-1 Milano. Original study: Nissen, Steven E., et al. "Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial." Jama 290.17 (2003): 2292-2300. [01:33:05] The Heart Protection (HPS) Study in the UK: Heart Protection Study Collaborative Group. "MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial." The Lancet 360.9326 (2002): 7-22. [01:33:36]  Scandinavian Simvastatin Survival Study (4S) Scandinavian Simvastatin Survival Study Group. "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)." The Lancet 344.8934 (1994): 1383-1389. [01:33:49] West of Scotland Coronary Prevention Study (WOSCOPS): Shepherd, James, et al. "Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia." New England Journal of Medicine 333.20 (1995): 1301-1308. [01:34:21] National Institute of Health’s ALLHAT-LLT trial: Officers, A. L. L. H. A. T. "Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)." JAMA 288.23 (2002): 2998-3007. [01:34:50] 2005 - Regulations guiding clinical trials changed. [01:35:14] Negative antidepressant studies not published; Study: Turner, Erick H., et al. "Selective publication of antidepressant trials and its influence on apparent efficacy." New England Journal of Medicine 358.3 (2008): 252-260. [01:37:11] Minnesota Coronary Experiment (MCE): Analysis of recovered data: Ramsden, Christopher E., et al. "Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)." bmj 353 (2016): i1246. [01:39:44] Why Most Published Research Findings Are False: Ioannidis, John PA. "Why most published research findings are false." PLoS medicine 2.8 (2005): e124. [01:39:55] Richard Horton, editor of the Lancet: half of what is published is not true: Horton, Richard. "Offline: What is medicine’s 5 sigma." Lancet 385.9976 (2015): 1380. [01:41:11] The problem with reproducibility; a database of clinical trials that cannot be challenged or reproduced. [01:42:37] Editors of prominent journals losing faith in published research: Marci Angell, Richard Smith [01:44:55] Parachute study: Yeh, Robert W., et al. "Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial." bmj 363 (2018): k5094. [01:46:01] Benefits that are major are obvious; no randomized clinical trial necessary. [01:48:33] Preventing vs. screening. [01:51:42] Podcast: Movement Analysis and Breathing Strategies for Pain Relief and Improved Performance with physical therapist Zac Cupples. [01:51:59] Analysis of women who died in various ways, examining breast tissue; found that a high % of women had what you could diagnose as breast cancer. Study: Bhathal, P. S., et al. "Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women." British journal of cancer 51.2 (1985): 271. [01:53:34] Screening programs not associated with reduced CVD or death; Study: Krogsbøll, Lasse T., et al. "General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis." Bmj 345 (2012): e7191. [01:54:26] Coronary Artery Calcium (CAC) scan. Podcast: Coronary Artery Calcium (CAC): A Direct Measure of Cardiovascular Disease Risk, with Ivor Cummins. [01:54:46] Cardiologist Bernard Lown.  [01:58:38] People who had measles/mumps less likely to get CVD; Study: Kubota, Yasuhiko, et al. "Association of measles and mumps with cardiovascular disease: The Japan Collaborative Cohort (JACC) study." Atherosclerosis 241.2 (2015): 682-686. [02:00:55] Life expectancy in US and UK is now falling. [02:06:46] Physical health doesn't exist without social health and psychological health. [02:07:40] Negative Twitter messages correlate with rates of heart disease; Study: Eichstaedt, Johannes C., et al. "Psychological language on Twitter predicts county-level heart disease mortality." Psychological science 26.2 (2015): 159-169. [02:09:58] People who take statins believe they’re protected so they stop exercising. Study: Lee, David SH, et al. "Statins and physical activity in older men: the osteoporotic fractures in men study." JAMA internal medicine 174.8 (2014): 1263-1270. [02:11:45] Simple changes: make friends, have good relationships, speak to your kids, exercise, eat natural food, sunshine. [02:16:53] Blood sugar measurements following funny lecture vs. boring lecture; Study: Hayashi, Keiko, et al. "Laughter lowered the increase in postprandial blood glucose." Diabetes care 26.5 (2003): 1651-1652. [02:18:08] Dr. Malcolm Kendrick’s blog.

Nella comunità medica, non c'è forse uomo più acclamato di Rudolf Virchow. Soprannominato il "Papa della Medicina", Virchow è responsabile di alcune delle più importanti scoperte che il mondo della Scienza Medica abbia mai registrato. Tuttavia, nel resto della comunità scientifica e specificatamente nella comunità evoluzionista, forse non c'è uomo più detestato

In diesem Podcast spricht Prof. Dr. med. Harald Schmidt mit dem Präsidenten des World Health Summits (WHS) in Berlin, Prof. Dr. med. Detlev Ganten, Charité, über diesen weltweit einen der wichtigsten Events globale Entwicklungen im Bereich Gesundheit zu diskutieren. Es geht darum wie und warum der WHS gegründet wurde und was es an spannenden Entwicklungen gibt. Interessante Neuigkeiten und Impulse warten auf dich. //   Hier die Details zum heutigen Interview-Gast: Prof. Dr. med. Detlev Ganten, Präsident, World Health Summit,   WHS Foundation GmbH, c/o Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, T +49 30 450 572102, F +49 30 450 572911, Email: detlev.ganten@charite.de.//   Eine Buchempfehlung: Prof. Dr. Detlev Ganten (Autor), Jochen Niehaus (Autor): “Die Gesundheitsformel: Die großen Zivilisationskrankheiten verstehen und verhindern” https://www.amazon.de/Die-Gesundheitsformel-Zivilisationskrankheiten-verstehen-verhindern/dp/3813506487/ref=sr_1_1?s=books&ie=UTF8&qid=1543146039&sr=1-1&keywords=Detlev+ganten+die+gesundheitsformel //   Der Link zum jährlichen World Health Summit: www.worldhealthsummit.org //   Informationen zu Rudolf Virchow: https://de.wikipedia.org/wiki/Rudolf_Virchow //   Informationen zum Wissenschaftsphilosophen Karl Popper, https://de.wikipedia.org/wiki/Karl_Popper, und seinem Buch “Logik der Forschung”, https://www.amazon.de/Logik-Forschung-Karl-R-Popper/dp/3161478371/ref=pd_sbs_14_1?_encoding=UTF8&pd_rd_i=3161478371&pd_rd_r=84fd9a81-f0a6-11e8-9b97-b1c6d07c4ee4&pd_rd_w=3M4qI&pd_rd_wg=Jbpae&pf_rd_i=desktop-dp-sims&pf_rd_m=A3JWKAKR8XB7XF&pf_rd_p=51bcaa00-4765-4e8f-a690-5db3c9ed1b31&pf_rd_r=TYWED5VWSNYYGNQGTT36&pf_rd_s=desktop-dp-sims&pf_rd_t=40701&psc=1&refRID=TYWED5VWSNYYGNQGTT36 //   Der heutige Pharmasong trägt den passenden Titel “Health” und ist von der Gruppe “Still Parade” und die B-Seite von deren Single “Actors”. Das Zitat lautet [...So take the photographs and still frames in your mind, hang it on a shelf of good health and good time...] //   Wenn der Podcast Ihnen gefallen hat bewerten Sie ihn bitte auf ITunes oder Spotify; so ist er für andere leichter zu finden. Auch freue ich mich über Anregungen, Fragen und konstruktive Kritik unter: LinkedIn: https://nl.linkedin.com/in/haraldschmidt; Twitter: @hhhw_schmidt; Facebook: harald.hhw.schmidt; Xing: Harald_Schmidt303; Instagram: hhhw_schmidt; oder Email: harald.schmidt@gesundheithoch3.de. Folge direkt herunterladen

Dr. Malcolm Kendrick is a medical doctor, author, speaker, and sceptic living in Cheshire, England.  His evidence-based arguments refute the lipid hypothesis and other ideas related to chronic illness that has resulted in a pervasive culture of fear and misinformation.  His popular blog features an ongoing series of posts on the real causes of heart disease, pointing to endothelial damage as a causal factor and nitric oxide as vital for preserving health. Dr. Kendrick is with us to share not only what really causes cardiovascular disease, but the specific environmental and psychosocial factors that cause the most harm, and what we need to do to maintain good health. We also discuss unexpected side effects of common medications and supplements and the healing power of specific micronutrients.  If you enjoy this podcast, you can support Dr. Kendrick’s work by pre-ordering his latest book, A Statin Nation: Damaging Millions in a Brave New Post-Health World, available 7/12/18. Here’s the outline of this interview with Malcolm Kendrick: [00:01:05] Book: The Great Cholesterol Con: The Truth About What Really Causes Heart Disease and How to Avoid it, by Malcolm Kendrick. [00:01:07] Book: Doctoring Data: How to Sort Out Medical Advice from Medical Nonsense, by Malcolm Kendrick. [00:01:14] The International Network of Cholesterol Skeptics (THINCS). [00:01:46] Trail Runner Nation Podcast: Metabolic Flexibility with Christopher Kelly. [00:02:59] Highlights email series. [00:03:01] Podcast: The True Root Causes of Cardiovascular Disease, with Jeffry Gerber. [00:03:07] Blog series: What causes heart disease? [00:05:28] Study: Hayashi, Keiko, et al. "Laughter lowered the increase in postprandial blood glucose." Diabetes care 26.5 (2003): 1651-1652. [00:06:20] Stress hormones, sympathetic nervous system. [00:07:32] Graph: Lithuanian death rate; Study: Kristenson, Margareta, et al. "Increased psychosocial strain in Lithuanian versus Swedish men: the LiVicordia study." Psychosomatic Medicine 60.3 (1998): 277-282. [00:08:25] Paul Rosch, M.D, founder of the American Institute of Stress. [00:10:20] Endothelium, glycocalyx. [00:11:12] Nitric Oxide (NO). [00:11:37] Alfred Nobel, nitroglycerin (glyceryl trinitrate, or GTN), Viagra. [00:13:13] Study: Andersson, Daniel P., et al. "Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction." Heart (2017): heartjnl-2016. [00:13:39] Sunlight as nitric oxide stimulant. [00:14:45] Vasculitis, Systemic lupus erythematosus (SLE), Rheumatoid arthritis, Sickle-cell disease. [00:17:05] Endothelial progenitor cells. [00:17:55] Carl von Rokitansky, Rudolf Virchow. [00:21:19] Endothelial damage required for arterial plaque. [00:21:52] Study: Law, M. R., and S. G. Thompson. "Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies." Cancer causes & control 2.4 (1991): 253-261. [00:23:49] Study: Ravnskov, Uffe, et al. "Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review." BMJ open 6.6 (2016): e010401. [00:25:03] Statins increasing NO, studies: 1, 2, 3. [00:26:52] Study: Lanphear, Bruce P., et al. "Low-level lead exposure and mortality in US adults: a population-based cohort study." The Lancet Public Health (2018). [00:28:17] Corticosteroids. [00:30:25] Familial Hypercholesterolemia. [00:34:56] Study: Winnik, Stephan, et al. "Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis–implications for cardiovascular safety." International journal of cardiology 168.3 (2013): 2453-2461. [00:36:29] QRISK survey for heart disease. [00:41:21] Inflammation as healing. [00:42:40] Study: Willis, G. C. "The reversibility of atherosclerosis." Canadian Medical Association Journal 77.2 (1957): 106. [00:44:36] Corticosteroids reduce inflammation, increase CVD risk, NSAIDs. [00:45:05] Study: Guilhem, Gaël, et al. "Effects of air-pulsed cryotherapy on neuromuscular recovery subsequent to exercise-induced muscle damage." The American journal of sports medicine 41.8 (2013): 1942-1951. [00:49:06] Lipoprotein A. [00:51:27] Vitamin C deficiency as possible cause of CVD. [00:53:01] Study: Lee, A. J., et al. "Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study." Journal of clinical epidemiology 43.9 (1990): 913-919. [00:55:27] Diabetes, triglycerides, sepsis, gingivitis as procoagulants. [00:58:39] Major endothelial offenders. [01:00:03] Study: Escolar, Esteban, et al. "The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)." Circulation: Cardiovascular Quality and Outcomes (2013): CIRCOUTCOMES-113. [01:01:03] Study: Douaud, Gwenaëlle, et al. "Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment." Proceedings of the National Academy of Sciences 110.23 (2013): 9523-9528. [01:01:44] Study: Marik, Paul E., et al. "Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study." Chest 151.6 (2017): 1229-1238. [01:02:27] Allen Smith, dying of flu, recovered with Vitamin C. [01:03:13] sunlight, viagra, stress management, alcohol. [01:04:23] Blue zones, strong social relationships. [01:05:07] Lifestyle and environmental factors associated with lower life expectancy. [01:13:05] Statins. [01:15:49] Absolute risk vs. relative risk; side effect vs. adverse effect, adverse events. [01:21:07] Problems caused by statins. [01:21:29] CoQ10, ATP. [01:23:47] Placebo effect, nocebo effect. [01:24:40] Study: Gupta, Ajay, et al. "Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase." The Lancet 389.10088 (2017): 2473-2481. [01:25:45] Study: Cohen, Jerome D., et al. "Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users." Journal of clinical lipidology 6.3 (2012): 208-215. [01:26:32] PCSK9 inhibitors. [01:27:54] Study: Sabatine, Marc S., et al. "Evolocumab and clinical outcomes in patients with cardiovascular disease." New England Journal of Medicine 376.18 (2017): 1713-1722. [01:35:16] L-arginine, citrulline. [01:39:34] Study: Tunstall-Pedoe, Hugh. "Does dietary potassium lower blood pressure and protect against coronary heart disease and death? Findings from the Scottish Heart Health Study?." Seminars in nephrology. Vol. 19. No. 5. 1999. [01:40:40] Study: Graudal, Niels. "A radical sodium reduction policy is not supported by randomized controlled trials or observational studies: grading the evidence." American journal of hypertension 29.5 (2016): 543-548. [01:43:55] Groupthink, cognitive bias. [01:44:21] Michael Alderman, M.D. [01:44:48] Evolutionary Psychology. [01:45:58] Peer Review. [01:51:36] Study: Bronstein, Alvin C., et al. "2010 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th Annual Report." Clinical Toxicology 49.10 (2011): 910-941. [01:52:57] Book: A Statin Nation: Damaging Millions in a Brave New Post-Health World, by Malcolm Kendrick.   [01:57:37] drmalcolmkendrick.org.

Dr Jeffry N. Gerber, MD, FAAFP is a board-certified family physician and owner of South Suburban Family Medicine in Littleton, Colorado, where he is known as “Denver’s Diet Doctor”. He has been providing personalized healthcare to the local community since 1993 and continues that tradition with an emphasis on longevity, wellness and prevention. In this interview, Dr Gerber describes the major root causes of cardiovascular disease, the most important of which is insulin-resistant Type 2 Diabetes. Worried about your heart disease risk? Get a coronary artery calcium (CAC) score. Your CAC score (and the rate of progression of your CAC score) is probably the best easily-available predictor of cardiac events. A recent paper from the CARDIA study also showed that an elevated CAC score was highly predictive of long-term heart disease risk in younger adults (18-30 year-olds). Here’s the outline of this interview with Dr. Jeffry N. Gerber, MD: [00:01:27] Clinical experience. [00:02:27] Interest in low-carb diets. [00:03:21] Presentation: Ivor Cummins: “Roads to Ruin?” The Pathways and Implications of Insulin Resistance. [00:03:38] Book: Diabetes Epidemic & You by Joseph R. Kraft. [00:04:23] Professor Grant Schofield and Catherine Crofts, PhD. Podcast: Hyperinsulinaemia and Cognitive Decline with Catherine Crofts, PhD. [00:05:08] Hyperinsulinemia and CVD. [00:06:39] The 2 hour insulin test < 30 UI/mL. [00:07:20] Fiorentino, Teresa Vanessa, et al. "One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose." The Journal of Clinical Endocrinology & Metabolism 100.10 (2015): 3744-3751. [00:07:51] < 5 UI/mL fasting insulin. [00:10:40] What causes CVD? [00:11:49] Carl von Rokitansky. [00:12:02] Rudolf Virchow. [00:12:19] Blog: Dr. Malcolm Kendrick. [00:13:49] Russell Ross. [00:15:40] List of things that cause CVD. [00:16:44] Nitric Oxide. [00:17:43] Jerry Reaven. [00:19:19] Vega, Gloria Lena, et al. "Triglyceride–to–high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men." Journal of Investigative Medicine 62.2 (2014): 345-349. [00:20:17] The Framingham study. [00:21:53] LDL-P and advanced testing. [00:22:32] CAC score. [00:23:41] Intimal media thickness. [00:26:11] Ordering a scan. [00:26:41] 64-slice EBCT machine. [00:27:08] Valenti, Valentina, et al. "A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals." JACC: Cardiovascular Imaging 8.8 (2015): 900-909. [00:28:15] Soft plaque. [00:28:57] CT angiogram. [00:29:44] Don't let perfect be the enemy of very good. [00:30:34] How to get a zero score. [00:31:28] Industrial seed oils. [00:32:02] D3/K2, magnesium, vitamin C. [00:33:29] Statins. [00:33:47] Absolute risk reduction data. [00:34:13] Ridker, Paul M., et al. "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein." New England Journal of Medicine 359.21 (2008): 2195. [00:34:40] NICE guidelines for prevention of cardiovascular disease. [00:36:45] Studies: Puri, Rishi, et al. "Impact of statins on serial coronary calcification during atheroma progression and regression." Journal of the American College of Cardiology 65.13 (2015): 1273-1282, Sattar, Naveed, et al. "Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials." The Lancet 375.9716 (2010): 735-742, and Preiss, David, et al. "Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis." Jama 305.24 (2011): 2556-2564. [00:37:22] Interview: Calcification and CAC with the Expert: Professor Matthew J. Budoff, MD, FAAC, Part 1 and Professor Matthew J. Budoff Part 2: Primary Care Physicians and CAC. [00:37:41] Book: Eat Rich, Live Long: Mastering the Low-Carb & Keto Spectrum for Weight Loss and Longevity by Ivor Cummins and Dr. Jeffry Gerber – February 6, 2018. [00:38:50] Four body types: Skinny, insulin-resistant type, the overweight, typical T2 diabetic type, the overweight, insulin-sensitive type, and the metabolically healthy type. [00:40:50] Conference: Low-Carb Breckenridge 2018. [00:41:28] Dr Rod Tayler. [00:42:25] Dr Andrew Mentee and the PURE study. [00:42:46] List of speakers at Low-Carb Breckenridge 2018. [00:43:06] IHMC STEM-Talk Episode 41: Dr David Diamond talks about the role of fat, cholesterol, and statin drugs in heart disease.         [00:44:15] Dr Jeffry N. Gerber, MD, FAAFP. [00:45:27] Rebuttal: 9NEWS – Explaining the science behind the keto diet with Dr Jeffrey Gerber.

Rudolf Virchow steht für das Ende eines über 2.000 Jahre alten Krankheitsbilds: Nicht die Mischung der Körpersäfte ist schuld, wenn der Mensch krank wird, sondern Störungen seiner Körperzellen. Autorin: Inga Pflug

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1873, the German scientist Rudolf Virchow declared in Parliament that liberals were locked in a Kulturkampf, a “culture war” with the forces of Catholicism, which he viewed as the chief hindrance to progress and modernity. Over the past two decades, historians have appropriated the term “culture war,” liberated it from its German origin and applied it as a generic expression for secular-catholic conflicts across nineteenth-century Europe. Intellectual and cultural historians have discovered in anti-catholicism a discourse and practice through which liberal ideas of subjectivity, sociability, and nation were constructed. Catholicism was, in short, the Other of a modernity understood to be rational, scientific and possibly Protestant. But what of those other religious Others of European modernity — the Jews? How did Jews relate to, contribute to, or perhaps oppose liberal anti-catholicism? What light do the polemics of Jewish anticlericals throw on one of the key topics of contemporary political philosophy, namely the theory of secularism? These are the questions explored in The Modernity of Others: Jewish Anti-Catholicism in Germany and France (Stanford University Press 2014), an ambitious work that takes the reader from the late Enlightenment to the twentieth century and across many disciplinary boundaries. Join us in this interview with the author, Ari Joskowicz, assistant professor of Jewish Studies and European Studies at Vanderbilt University. Learn more about your ad choices. Visit megaphone.fm/adchoices